Predominantly cell surface with some cytoplasmic Antibodies

Predominantly cell surface with some cytoplasmic

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK